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Abstract : Human intestinal absorption (HIA) will dictate biopharmaceutical performance through its 
inﬂuence on absorption, distribution, metabolism, and elimination and can vary signiﬁcantly 
depending upon the nature of the compound under consideration. In this study, an in vitro assay 
method is proposed for the prediction of HIA through the measurement of drug solubility in an 
aqueous phase containing micellar bile salt, namely sodium deoxycholate. A series of twenty 
compounds, displaying a range of physico- chemical properties and known HIA values, were 
analyzed using UV spectroscopy to determine a solubilization ratio for each compound. A 
micelle/water partition coefﬁcient (Kxm/a) was calculated and then used to develop an equation 
through simple linear regression; logit HIA =  -0.919 + 0.4618 logKxm/a (R2  = 0.85). From this 
equation,  a value for  % HIA was determined  which compared well with    literature. 
Furthermore, 4 additional drugs were then analyzed using the developed equation and found to match 
well with literature, conﬁrming the suitability of the method. Using a simple, economic, and robust UV 
bile salt assay allows prediction of HIA and avoids many of the disadvantages of other techniques, 
such as animal-based methods. 
Introduction 
Human intestinal absorption (HIA) is the mechanism through which drugs traverse from the intestine into  the  
bloodstream.  The vast majority of active pharmaceutical ingredients are administered orally; thus, it is essential 
that  they  are  absorbed  within  the  intestine to reach the intended site of action. Although  it is  possible  to 
measure the percent HIA (% HIA) during clinical studies, it is far more useful to be able to predict the value much 
earlier on during drug development. It is for this reason that a signiﬁcant amount of research has been undertaken 
in an attempt to develop a reliable, robust,  and accurate method to predict %    HIA. 
Several different predictive approaches have been undertaken, including computational (in silico) 
methods,1,2 such as quantitative structure-activity relationships3,4 and physiologically based phar-
macokinetic modelling.5 These techniques have a clear    advantage
in that they remove the need for costly laboratory-based experi- mental measurement yet their 
predictive ability can be limited. 
In vitro models for the prediction of absorption include the application of dissolution analysis,6
chromatographic analysis,7 and dynamic gastric models.8 Many of these in vitro models have included
the presence of physiologically relevant solvent compo- sitions, mainly because it is known that solvent 
composition dictates intestinal drug solubility which, in turn, is an important 
factor  in  determining  the  rate,  and  extent,  of  absorption.9    The
speciﬁc components within human intestinal ﬂuids that dramati- cally alter drug solubility are bile salts. The 
main biological function of bile salts is to solubilize lipids and vitamins in the intestine  with 
a similar effect encountered for orally administered drugs. For a full review of  the  absorption-enhancing 
effects  of  bile salts.10
In humans, the composition of bile salts is rather complex and for the purposes of this study was 
simpliﬁed to consider 1 bile salt in particular, namely sodium deoxycholate (NaDC). NaDC is a well- 
characterized  amphiphilic  molecule  which  can  undergo micellar 
aggregation,11,12  stabilized  by  polar  interactions,13  with compara-
tively small aggregation numbers as a result of the rigid molecular structure.14 Previous research within
our group has shown that NaDC, when in the presence of drugs, will exhibit modiﬁed  physi- 
cochemical properties, for example, a variable (drug-speciﬁc) reduction in critical micellar 
concentration.15
When quantifying (or comparing) enhancement in solubility for a speciﬁc drug, or series of drugs, it is 
possible to evaluate the solubilization ratio (SR), where SR is equal to the moles of drug solubilized per mole 
of bile salt. One study in particular  calculated SR for a series of steroids and then used these data to 
calculate micelle/water   partition   coefﬁcients   (Km/w)   which   were    then 
correlated with octanol/water partition coefﬁcients (Po/w).16  Using
this same theory as a basis for drug-NaDC measurement, this article describes the evolution of measuring 
SR and then using these values as the basis to form an equation to permit prediction of % HIA, thereby 
presenting an in vitro method to predict in vivo behavior. 
Materials and Methods 
Materials 
Aqueous solutions of NaDC (97%), used as purchased from Sigma-Aldrich (Dorset, UK), were 
prepared by dilution from a 20 mM stock solution with distilled water as necessary to achieve 
concentrations of 7, 9, 11, 13, 17, and 20 mM (i.e., always at con- centrations greater than the stable 
micelle critical micellar    con- 
centration of NaDC12). The following 24 compounds considered  in
this work were used as purchased: acetaminophen (99%; Sigma- Aldrich), acetyl salicylic acid (99%; Acros 
Organics, Geel, Belgium), alprenolol (98%; Sigma-Aldrich), amitriptyline (98%; Sigma- Aldrich), 
carbamazepine (99%; Sigma-Aldrich), cimetidine (Sigma- Aldrich), diclofenac (98%; TCI Europe, 
Zwijndrecht, Belgium), diphenhydramine (98%; TCI Europe), fenoprofen (97%; Fluka, Dorset, UK), 
ﬂuconazole (98%; Sigma-Aldrich), ﬂurbiprofen (98%; TCI Europe), gemﬁbrozil (98%; TCI Europe), ibuprofen 
(98%; BASF, Cheshire, UK), indomethacin (99%; Sigma-Aldrich), ketoprofen (98%; Sigma-Aldrich), 
lidocaine (98%, Sigma-Aldrich), mannitol (98%; Sigma-Aldrich), meloxicam (98%; TCI Europe), naproxen 
(98%;  Sigma-Aldrich),  phenylbutazone  (99%;  Sigma-Aldrich), pir- 
oxicam (98%, Sigma-Aldrich), propranolol (99%; Sigma-Aldrich), quinine (96%; Fluka), and terbutaline (96% 
Sigma-Aldrich). All experimental work was conducted without altering the pH  or  ionic strength to avoid the 
formation of a surfactant-gel hydropolymer. 
Method 
A calibration plot was established at each of the 6 bile salt concentrations using the Agilent Cary 60 UV-
Vis Spectrophotom- eter set at wavelength of maximum absorbance for each drug as follows: 
acetaminophen ʎmax. 243 nm, acetyl salicylic acid ʎmax. 295 nm, alprenolol ʎmax. 270 nm, amitrityline 
ʎmax. 240 nm, carba- mazepine ʎmax. 284 nm, cimetidine ʎmax. 218 nm, diclofenac ʎmax. 276 nm, 
diphenhydramine ʎmax. 221 nm, fenoprofen ʎmax. 271 nm, ﬂuconazole ʎmax. 260 nm, ﬂurbiprofen ʎmax. 
247 nm, gemﬁbrozil ʎmax. 274 nm, ibuprofen ʎmax. 272 nm, indomethacin ʎmax. 320 nm, ketoprofen ʎmax. 
261 nm, lidocaine ʎmax. 262 nm, mannitol ʎmax.   295 nm, meloxicam ʎmax. 362 nm, naproxen ʎmax. 230 
nm, phen- ylbutazone ʎmax. 264 nm, piroxicam ʎmax. 355 nm, propranolol  ʎmax. 292 nm, quinine ʎmax. 
332 nm, terbutaline ʎmax. 280 nm;   also, 
the sample cell was thermostated at 37oC. Separately, an excess of 
þdrug was added to 1 mL of each bile salt concentration in a microcentrifuge tube and placed in a shaking 
water bath for 48 h at 37oC, then centrifuged at 13,000 rpm, ﬁltered, and diluted using the corresponding 
bile salt concentration. Using the regression equa- tion obtained from the established calibration plot of each 
drug at each bile salt concentration, the concentration of solubilized drug was determined. A plot of the 
amount solubilized with bile  salt concentration facilitated calculation of the SR whereby the mole fraction 
solubilized (Xm) is equal to SR/(1 SR) and can be com- bined with the literature-based calculated mole 
fraction aqueous solubility (Xa) to determine the micelle/water partition coefﬁcient 
(Kxm/a) as follows17:  Kxm/a=Xm/Xa
Results from the UV analysis permitted the development of a dataset that contained logKxm/a values 
for 20 compounds along with their physicochemical parameters (e.g., molecular weight, rotatable bonds, 
molar volume, number of hydrogen bond accep- tors) and published HIA values, facilitating development 
of an equation to relate logKxm/a with HIA using simple linear regression in  combination with  the 
established equation: 
Logit HIA = log [½% HIA/(100 - % HIA)]18
A further 4 compounds were then similarly analyzed by measuring logKxm/a to predict % HIA. A 
comparison was then made between the predicted values and those published in literature. Simple linear 
regression analysis was carried out using Minitab 17® (Minitab Inc., State College, PA; licensed to the 
University of Hud- dersﬁeld)  where the previously mentioned dataset was    imported 
into it. The ﬁnal model was obtained by excluding molecular de- scriptors which were not statistically 
signiﬁcant (p value > 0.05), and those with unacceptably high levels of variance inﬂation factor, which is 
considered as a multicollinearity indicator, were not included in the ﬁnal model. Cook’s distance and 
residuals were used to detect whether any of the model variables had high leverage. The optimal ﬁnal 
model was then obtained including only logKxm/a as a predictor for logit HIA, and the model was then vali- 
dated using 4 compounds. 
Results and Discussion 
In total, 24 drugs were analyzed to determine the concentration of drug in solution as a function of NaDC 
concentration; these were selected to cover a range of physicochemical properties, such as reported HIA, 
log Po/w, and other properties. All data were then plotted to determine a SR value for each drug (i.e., the 
slope), a selection of which can be seen in Figure   1. 
Figure 1 clearly shows a linear relationship between the con- centration of drug and the 
concentration of NaDC. Only linear sections of the plots were incorporated to calculate SR, some were 
deemed to be nonlinear, such as the lower concentrations of qui- nine and the higher concentrations 
of acetaminophen (data not shown). These nonlinear relationships may be due to preferential drug-
drug interactions rather than drug-NaDC interactions as suchdrugs are known to self-associate.19 The
majority of the compounds did exhibit a linear relationship  over  the  concentration  range  studied (7-20 mM), 
ensuring conﬁdence in  the  experimental  sys-  tem. Using the calculated SR value, along with the mole fraction 
of aqueous solubility for the drug, facilitated calculation of a micelle/ aqueous partition coefﬁcient for each drug. 
Analyzing these values alongside reported % HIA literature data (Table 1) enabled the application of simple 
linear regression to construct an equation to permit calculation of % HIA for any compound through  measure- 
ment of its solubility in  NaDC. 
Figure 1. Plots of the concentration of a selection of analyzed compounds in solution with NaDC 
concentration to determine the SR. Each data point = mean, n = ≥3, ±SD . 
Using data presented in Table 1, simple linear regression analysis was used to create an optimized 
equation to predict  HIA: 
The p values obtained for this model indicate that the relationship between % HIA and logKxm/a values was 
statistically significant at the 95% confidence level where they were <0.05, and the model’s F-ratio was found to 
be statistically significant. Also, logKxm/a was found to have a 95% confidence interval of 0.365-0.558 and a t-
value of 10.069. According to Cook’s distance and residuals, no drug among the model’s dataset was found to 
be influential or having high leverage. The unadjusted R2 of 0.8492 derived from the current data indicates that 
the fit of the sampled drugs to the model is good. The View the MathML source R2 (Pred) value of 0.8232 
indicates that the fit of the drugs to the model is valid and confirms the potential suitability of UV measurement of 
solubility using NaDC to predict oral drug absorption in the human GI tract. The close values of View the 
MathML source R2 (adj.) and View the MathML source R2 (Pred) show no evidence of the current model 
overfitting the data. A Durbin-Watson statistic value of 2.309 proves the absence of autocorrelation in the current 
regression model. A summary of predicted % HIA values using the established equation alongside published 
literature values for % HIA can be seen in Table 2 including validation compounds.
A plot of  calculated  %  HIA with  corresponding  literature values can be seen in Figure  2. 
Conclusions 
Overall, the development of an equation to predict % HIA using a simple UV-based technique via 
calculation of the micelle/water partition coefﬁcient has been shown to be statistically appropriate 
and reliable as a method to determine intestinal absorption. Using a simple, economic, and robust 
UV bile salt assay allows prediction of HIA and avoids many of the disadvantages of other techniques, 
such as animal-based methods. 
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